ConductScience.org, home

Paper20122366

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

McElroy SL and 10 others. J Clin Psychiatry, 2010. Cited by 233 papers, by iCite.

Cite this record

ConductScience Library. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). Papers, record 20122366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20122366

Download JSON
Disease
bipolar disorder173 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
PubMed
Journal
J Clin Psychiatry
PubMed
Year
2010
PubMed
Publication types
Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
233
iCite
Relative citation ratio, by iCite
8.46
iCite
Revised in PubMed
2026-05-18
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McElroy SLSusan L
2Weisler RHRichard H
3Chang WWilliam
4Olausson BBengt
5Paulsson BBjörn
6Brecher MMartin
7Agambaram VVasavan
8Merideth CCharles
9Nordenhem AArvid
10Young AHAllan H
11EMBOLDEN II (Trial D1447C00134) InvestigatorsGroup

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive AgentsMajor topic
Antidepressive Agents, Second-GenerationMajor topic
Antimanic AgentsMajor topic
Bipolar DisorderMajor topic
DibenzothiazepinesMajor topic
ParoxetineMajor topic
Adolescent
Adult
Aged
Double-Blind Method
Female
Humans
Male
Middle Aged
Placebos
Psychiatric Status Rating Scales
Quetiapine Fumarate
Severity of Illness Index
Treatment Outcome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00119652Seroquel in Bipolar Depression Versus SSRIDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Cited by94

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 233 citations.

PMIDTitleJournalYearIn PapersSource
42968118
INTENSIFY-a randomized, controlled trial to investigate the effect of an early intensified pharmacological treatment for major psychiatric disorders after treatment failure in the current episode: a study protocol.
Trials2026https://conductscience.org/library/papers/42968118PubMed
42278457The Role of the Ketogenic Diet in Modulating Biochemical Pathophysiology in Psychiatric and Neurodegenerative Disorders.Int J Mol Sci2026https://conductscience.org/library/papers/42278457PubMed
42204011Efficacy and safety of pharmacological and non-invasive brain stimulation for adolescent bipolar depression: a systematic review and network meta-analysis.Int J Bipolar Disord2026https://conductscience.org/library/papers/42204011PubMed
41856598
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocol.
BMJ Open2026https://conductscience.org/library/papers/41856598PubMed
40864439Antipsychotic Drugs and Dysregulated Glucose Homeostasis: A Systematic Review and Meta-Analysis.JAMA Psychiatry2025https://conductscience.org/library/papers/40864439PubMed
40823496Switch to mania after acute antidepressant treatment for bipolar depression: a systematic review and network meta-analysis of randomised controlled trials.EClinicalMedicine2025https://conductscience.org/library/papers/40823496PubMed
40694062Lumateperone monotherapy for major depressive episodes associated with bipolar disorder: efficacy and safety in a randomized placebo-controlled trial.Int Clin Psychopharmacol2026https://conductscience.org/library/papers/40694062PubMed
40630973Systematic Review of Second-Generation Antidepressant Monotherapy for Acute Bipolar-II Depression.Psychopharmacol Bull2025https://conductscience.org/library/papers/40630973PubMed
40355996Antidepressants in Bipolar Depression: From Neurotransmitter Mechanisms to Clinical Challenges.Actas Esp Psiquiatr2025https://conductscience.org/library/papers/40355996PubMed
39755917Untangling the complex relationship between bipolar disorder and anxiety: a comprehensive review of prevalence, prognosis, and therapy.J Neural Transm (Vienna)2025https://conductscience.org/library/papers/39755917PubMed
39754520Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans.Phytother Res2025https://conductscience.org/library/papers/39754520PubMed
39170573Progress and trends of research on mineral elements for depression.Heliyon2024https://conductscience.org/library/papers/39170573PubMed
38487836Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis.Eur Psychiatry2024https://conductscience.org/library/papers/38487836PubMed
37683232Antidepressant-Associated Treatment Emergent Mania: A Meta-Analysis to Guide Risk Modeling Pharmacogenomic Targets of Potential Clinical Value.J Clin Psychopharmacol2023https://conductscience.org/library/papers/37683232PubMed
36513812Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania.Mol Psychiatry2023https://conductscience.org/library/papers/36513812PubMed
35778967A systematic review and meta-analysis of treatments for rapid cycling bipolar disorder.Acta Psychiatr Scand2022https://conductscience.org/library/papers/35778967PubMed
34658633Acute and Maintenance Treatment of Bipolar Depression.Noro Psikiyatr Ars2021https://conductscience.org/library/papers/34658633PubMed
33975574Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.BMC Psychiatry2021https://conductscience.org/library/papers/33975574PubMed
32047367Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better.Focus (Am Psychiatr Publ)2019https://conductscience.org/library/papers/32047367PubMed
31932883[German S3 guidelines on bipolar disorders-first update 2019 : What is new in pharmacotherapy?]Nervenarzt2020https://conductscience.org/library/papers/31932883PubMed

See all 94 cited byDownload CSV of cited by

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
QUETIAPINE FUMARATECHEMBL3188993Derived from the trial1https://conductscience.org/library/drugs/CHEMBL3188993ChEMBL
PAROXETINECHEMBL490Derived from the trial1https://conductscience.org/library/drugs/CHEMBL490ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20122366

GET https://conductscience.org/api/papers/v1/20122366/cited_by?page=2